JP2020015665A - External preparation for skin - Google Patents

External preparation for skin Download PDF

Info

Publication number
JP2020015665A
JP2020015665A JP2018137330A JP2018137330A JP2020015665A JP 2020015665 A JP2020015665 A JP 2020015665A JP 2018137330 A JP2018137330 A JP 2018137330A JP 2018137330 A JP2018137330 A JP 2018137330A JP 2020015665 A JP2020015665 A JP 2020015665A
Authority
JP
Japan
Prior art keywords
extract
skin
external preparation
cordyceps
glyceryl glucoside
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018137330A
Other languages
Japanese (ja)
Other versions
JP6416433B1 (en
Inventor
伸幸 宮地
Nobuyuki Miyaji
伸幸 宮地
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noevir Co Ltd
Original Assignee
Noevir Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noevir Co Ltd filed Critical Noevir Co Ltd
Priority to JP2018137330A priority Critical patent/JP6416433B1/en
Application granted granted Critical
Publication of JP6416433B1 publication Critical patent/JP6416433B1/en
Publication of JP2020015665A publication Critical patent/JP2020015665A/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Cosmetics (AREA)

Abstract

To provide an external preparation for skin which is synergistically improved in moisturizing effect by using glyceryl glucoside and a specific plant in combination.SOLUTION: There is provided an external preparation for skin which comprises the following (A) and (B): (A) glyceryl glucoside and (B) one or two or more kinds selected from a Sasa albo-marginata extract, a Murraya koenigii extract, and a cordyceps extract.SELECTED DRAWING: Figure 1

Description

本発明は、グリセリルグルコシドと、特定の植物抽出物を併用してなる皮膚外用剤に関する。   The present invention relates to an external preparation for skin comprising a combination of glyceryl glucoside and a specific plant extract.

グリセリルグルコシドは、高い保湿効果を有することが知られている。(特許文献1)
クマザサ抽出液を含有する皮膚外用剤が保湿効果を有し、細胞間脂質であるセラミドの合成促進作用に優れていることが知られている。(特許文献2)
冬虫夏草を超臨界流体又は亜臨界流体により抽出して得られる抽出物を含有する皮膚外用剤が優れた保湿効果を有することが知られている。(特許文献3)
ムラヤコエンジー抽出物を含有する皮膚化粧料が優れた紫外線吸収効果及び保湿性を有することが知られている。(特許文献4)
Glyceryl glucoside is known to have a high moisturizing effect. (Patent Document 1)
It is known that an external preparation for skin containing Kumazasa extract has a moisturizing effect and is excellent in promoting the synthesis of ceramide which is an intercellular lipid. (Patent Document 2)
It is known that an external preparation for skin containing an extract obtained by extracting Cordyceps with a supercritical fluid or a subcritical fluid has an excellent moisturizing effect. (Patent Document 3)
It is known that skin cosmetics containing Murayakoenji extract have excellent ultraviolet absorbing effect and moisture retention. (Patent Document 4)

特開平11−222496号公報JP-A-11-222496 特開平11−199467号公報JP-A-11-199467 特開2003−292430号公報JP-A-2003-292430 特開平7−118132号公報JP-A-7-118132

本発明は、グリセリルグルコシドと、特定の植物を併用することにより、保湿効果が相乗的に向上する皮膚外用剤を提供することを課題とする。   An object of the present invention is to provide an external preparation for skin that has a synergistic moisturizing effect by using glyceryl glucoside in combination with a specific plant.

本発明は、
下記(A)及び(B)を含有する皮膚外用剤
(A)グリセリルグルコシド
(B)クマザサ抽出物、ムラヤコエンジー抽出物、冬虫夏草抽出物から選択される1種または2種以上
を提供する。
The present invention
Provided is one or more selected from the group consisting of (A) glyceryl glucoside (B) Kumazasa extract, Murayakoenji extract, and Cordyceps sinensis extract containing the following (A) and (B).

本発明の皮膚外用剤は、グリセリルグルコシドと特定の植物を併用して用いることにより、保湿効果が相乗的に向上する。   The skin external preparation of the present invention synergistically improves the moisturizing effect by using glyceryl glucoside in combination with a specific plant.

図1は、グリセリルグルコシドとクマザサ抽出物を併用することにより、角層水分量が相乗的に向上することを示す図である。FIG. 1 is a diagram showing that the combined use of glyceryl glucoside and Kumazasa extract synergistically improves the water content of the stratum corneum. 図2は、グリセリルグルコシドとムラヤコエンジー抽出物を併用することにより、角層水分量が相乗的に向上することを示す図である。FIG. 2 is a diagram showing that the water content of the stratum corneum is synergistically improved by the combined use of glyceryl glucoside and Murayakoenji extract. 図3は、グリセリルグルコシドと冬虫夏草抽出物を併用することにより、角層水分量が相乗的に向上することを示す図である。FIG. 3 is a diagram showing that the combined use of glyceryl glucoside and a cordyceps extract enhances the water content of the stratum corneum synergistically.

以下本発明を実施するための形態を説明する。   Hereinafter, embodiments for carrying out the present invention will be described.

本発明の皮膚外用剤は、化粧品、医薬部外品、医薬品等のいずれの用途にも用いられ得る。   The external preparation for skin of the present invention can be used for any of cosmetics, quasi-drugs, pharmaceuticals and the like.

グリセリルグルコシドは、化粧料に配合し得るものであれば製造方法は、合成、微生物により発酵法等を問わない。具体的には、α体、β体、或いはこれらの混合物のいずれも用いることができる。   As long as glyceryl glucoside can be blended into cosmetics, the production method is not limited to synthesis, fermentation method, etc. depending on the microorganism. Specifically, any of α-form, β-form and a mixture thereof can be used.

本発明で用いるクマザサ抽出物は、イネ科ササ属のクマザサ(Sasa veitchii)の抽出物である。抽出部位としては葉、茎、全草、地上部位から選択される1種または2種以上を用いる。葉を用いることが好ましい。クマザサ抽出物として市販の、ファルコレックス クマザサ E(製造元:一丸ファルコス)、クマザサ抽出液(製造元:丸善製薬)、クマザサ抽出液(製造元:香栄興業株式会社)等を用いることもできる。   The Kumazasa extract used in the present invention is an extract of Sasa veitchii belonging to the genus Sasa of the Poaceae family. As the extraction site, one or more selected from leaves, stems, whole plants, and above-ground sites are used. It is preferred to use leaves. As the Kumazasa extract, commercially available Falco Rex Kumazasa E (manufacturer: Ichimaru Falcos), Kumazasa extract (manufacturer: Maruzen Pharmaceutical), Kumazasa extract (manufacturer: Koei Kogyo Co., Ltd.) and the like can also be used.

本発明で用いるムラヤコエンジー抽出物は、ミカン科ゲッキツ属のオオバゲッキツ(Murraya koenigii;Chalcas koenigii)の抽出物である。抽出部位としては葉及び枝先、又は葉を用いる。葉を用いることが好ましい。ムラヤコエンジー抽出物として市販の、ムラヤコエンジー抽出液(製造元:御木本製薬株式会社)を用いることもできる。   The extract of Murayakoenji used in the present invention is an extract of Murakaya koenigii (Chalcas koenigii) belonging to the genus Rutaceae. A leaf and a branch tip or a leaf is used as an extraction site. It is preferred to use leaves. A commercially available Murayaco Enzyme extract (manufacturer: Mikimoto Pharmaceutical Co., Ltd.) can also be used as the Murayaco Enzyme extract.

本発明において用いる冬虫夏草は特に制限はなく、一般に知られている蝶蛾類鱗翅目および鞘翅日の昆虫又はその幼虫に寄生してその体内の菌核を形成し、夏季に宿主である昆虫又はその幼虫の体表面に形成される子実体であればよい。本発明においては特に好ましく使用可能な冬虫夏草としては、コウモリ蛾科の幼虫(Hepialus armoricanus Ober)に寄生してその体内に菌核を形成し、夏季に頭部から根棒状の子実体を形成するコルダイセプシネンシス(Cordyceps sinensis)が挙げられる。また、コルダイセプシネンシス以外の冬虫夏草で生薬として薬効のあるものとしてはセミタケ(Cordyceps sobolifera B)やサナギタケ(Cordyceps militaris Link)、ミミカキタケ(Cordyceps nutans Pat)などが知られており、これらも本発明において好ましく使用できるものである。本発明にかかる方法により、これらの冬虫夏草であって、有効成分を産生するものであればいずれの場合も抽出可能である。また、本発明にかかる方法を用いることにより、子実体又は被子体の区別なく抽出可能であるが、特に高収量で得るためには、コルダイセプシネンシスの子実体からの抽出が好ましい。   There are no particular restrictions on the cordyceps used in the present invention, and the parasites of commonly known butterfly moths, Lepidoptera and Coleoptera, or parasites of the larvae of the insects or larvae, form sclerotium inside the body, and the host insects or their insects in summer. Any fruiting body formed on the body surface of the larva may be used. Cordyceps which can be particularly preferably used in the present invention include parasites of bat moths (Hepialus armoricanus Ober), which form sclerotium in their bodies and form root-rod-like fruiting bodies from their heads in summer. Cordyceps sinensis. Also, as cordyceps sinensis other than Cordycepsinensis and having a medicinal effect as a crude drug, there are known semi-bamboo (Cordyceps sobolifera B), pupa (Cordyceps militaris Link), mimikitake mushroom (Cordyceps nutans Pat) and the like, and these are also used in the present invention. It can be preferably used. By the method according to the present invention, any of these cordyceps can be extracted as long as they produce an active ingredient. Further, by using the method according to the present invention, extraction can be performed without distinction between fruiting bodies and angiosperms. However, in order to obtain particularly high yield, extraction from the fruiting bodies of Cordycepsinensis is preferred.

本発明において用いる植物抽出物の抽出方法について述べる。   A method for extracting a plant extract used in the present invention will be described.

本発明において、上記各植物は生のまま抽出に供してもよいが、抽出効率を考えると、細切,乾燥,粉砕等の処理を行った後に抽出を行うことが好ましい。抽出は、抽出溶媒に浸漬して行う。抽出効率を上げるため撹拌を行ったり、抽出溶媒中でホモジナイズしてもよい。抽出温度としては、5℃程度から抽出溶媒の沸点以下の温度とするのが適切である。抽出時間は抽出溶媒の種類や抽出温度によっても異なるが、4時間〜14日間程度とするのが適切である。   In the present invention, each of the above plants may be subjected to extraction as it is, but in consideration of extraction efficiency, it is preferable to perform extraction after performing processing such as shredding, drying, and pulverization. The extraction is performed by immersion in an extraction solvent. Stirring may be performed to increase the extraction efficiency, or homogenization may be performed in an extraction solvent. It is appropriate to set the extraction temperature to a temperature of about 5 ° C. to a temperature not higher than the boiling point of the extraction solvent. The extraction time varies depending on the type of the extraction solvent and the extraction temperature, but is suitably about 4 hours to 14 days.

抽出溶媒としては、水の他、メタノール,エタノール,プロパノール,イソプロパノール等の低級アルコール、1,3-ブチレングリコール,プロピレングリコール,ジプロピレングリコール,グリセリン等の多価アルコール、エチルエーテル,プロピルエーテル等のエーテル類、酢酸エチル,酢酸ブチル等のエステル類、アセトン,エチルメチルケトン等のケトン類などの極性有機溶媒を用いることができ、これらより1種又は2種以上を選択して用いる。また、生理食塩水,リン酸緩衝液,リン酸緩衝生理食塩水等を用いてもよい。   Examples of the extraction solvent include water, lower alcohols such as methanol, ethanol, propanol, and isopropanol; polyhydric alcohols such as 1,3-butylene glycol, propylene glycol, dipropylene glycol, and glycerin; and ethers such as ethyl ether and propyl ether. And polar organic solvents such as esters such as ethyl acetate and butyl acetate, and ketones such as acetone and ethyl methyl ketone. One or more of these can be selected and used. Further, physiological saline, phosphate buffer, phosphate buffered saline, and the like may be used.

上記植物の上記溶媒による抽出物は、そのままでも本発明に係る組成物に含有させることができるが、濃縮,乾固したものを水や極性溶媒に再度溶解したり、或いはそれらの皮膚生理機能向上作用を損なわない範囲で脱色,脱臭,脱塩等の精製処理を行ったり、カラムクロマトグラフィーによる分画処理を行った後に用いてもよい。また保存のため、精製処理の後凍結乾燥し、用時に溶媒に溶解して用いることもできる。また、リポソーム等のベシクルやマイクロカプセル等に内包させて用いることもできる。   The extract of the above-mentioned plant with the above-mentioned solvent can be contained in the composition according to the present invention as it is, but the concentrated and dried one is redissolved in water or a polar solvent, or their skin physiological function is improved. It may be used after performing purification treatment such as decolorization, deodorization, and desalting within a range that does not impair the action, or performing fractionation treatment by column chromatography. For preservation, it can be freeze-dried after the purification treatment and dissolved in a solvent before use. It can also be used by being encapsulated in vesicles such as liposomes or microcapsules.

特に皮膚外用剤として用いる場合、上記抽出物はリポソーム等のベシクルやマイクロカプセル等に内包させて用いることにより、経皮吸収が高まり、より高い老化防止効果を発揮する。   In particular, when used as an external preparation for skin, the extract is contained in vesicles such as liposomes, microcapsules, or the like, whereby percutaneous absorption is enhanced and a higher anti-aging effect is exhibited.

なお、冬虫夏草の抽出方法としては、熱水抽出物を用いることが本発明の効果の点から好ましい。   As a method for extracting cordyceps, it is preferable to use a hot water extract from the viewpoint of the effect of the present invention.

本発明における上述の植物の組成物への配合量としては、好ましくは0.00001〜5重量%、特に0.0001〜1重量%の範囲である。この範囲であれば、特定の植物を組み合わせて配合した場合、製剤及び製剤中の植物の経時安定性に影響を及ぼすことが無く、より高い効果を発揮させることができる。   The compounding amount of the above-mentioned plant in the present invention in the composition is preferably 0.00001 to 5% by weight, particularly 0.0001 to 1% by weight. Within this range, when a specific plant is combined and blended, a higher effect can be exhibited without affecting the temporal stability of the preparation and the plants in the preparation.

本発明の皮膚外用剤には上述の必須成分の他に、必要に応じて通常皮膚外用剤に配合される、水性成分、油性成分、保湿剤、色素、界面活性剤、紫外線吸収剤、増粘剤、美容成分、香料、高分子物質、防菌防微剤、アルコール類、粉体、スクラブ剤、生体由来成分等を適宜配合することができる。   In addition to the above-mentioned essential components, the skin external preparation of the present invention usually contains an aqueous component, an oily component, a humectant, a pigment, a surfactant, an ultraviolet absorber, and a thickener, which are usually added to the skin external preparation as needed. Agents, beauty ingredients, fragrances, high molecular substances, antibacterial and antimicrobial agents, alcohols, powders, scrubbing agents, biological components and the like can be appropriately compounded.

本発明の皮膚外用剤は、例えば、ローション剤、乳剤、軟膏の剤型で用いることができる。また、本発明の皮膚外用剤は、製造方法を問わない。   The external preparation for skin of the present invention can be used, for example, in the form of lotions, emulsions, and ointments. Further, the method for producing the external preparation for skin of the present invention does not matter.

以下、実施例により本発明を具体的に説明するが、これにより本発明の範囲が限定されるものではない。なお、配合量は特に断りのない限り質量%である。   Hereinafter, the present invention will be described specifically with reference to Examples, but the scope of the present invention is not limited thereto. In addition, the compounding quantity is a mass% unless there is particular notice.

まず、使用した各植物の抽出物の調製例を示す。   First, preparation examples of extracts of each plant used will be described.

[クマザサ抽出物]
クマザサ抽出物として香栄興業株式会社製の製品名クマザサ抽出液を用いた。
[Kumazasa extract]
Kumazasa extract manufactured by Koei Kogyo Co., Ltd. was used as Kumazasa extract.

[ムラヤコエンジー抽出物]
ムラヤコエンジ―抽出物として御木本製薬株式会社製の製品名ムラヤコエンジー抽出液を用いた。
[Murayakoenji extract]
Murayakoenji extract was used as the Murayakoenji extract.

[冬虫夏草抽出物]
チベット産冬虫夏草(Cordyceps sinensis)の子実体を乾燥、粉砕し、10質量倍量の熱水で2時間抽出する。ろ過後ろ液を減圧乾燥し、エキス純分1質量%となるように、精製水に溶解後、48時間熟成し再度ろ過したものを冬虫夏草抽出物とした。
[Cordyceps extract]
The fruit body of Cordyceps sinensis, a Tibetan cordyceps, is dried, pulverized, and extracted with 10 times by mass of hot water for 2 hours. The liquid after filtration was dried under reduced pressure, dissolved in purified water so that the extract content became 1% by mass, aged for 48 hours, and filtered again to obtain a cordyceps extract.

[グリセリルグルコシド]
グリセリルグルコシドとして、辰馬本家酒造社製α−GGを用いた。
[Glyceryl glucoside]
As glyceryl glucoside, α-GG manufactured by Tatsuma Honke Shuzo was used.

[保湿効果試験方法]
・被験者は、試験前1週間前腕に化粧料を使用しないよう指導のもと試験を行った。
・まず前腕部を泡立てた洗浄料で洗浄した。
・前腕の水分をふき取り、21±0.5℃、相対湿度50±5%の環境下で15分間安静に保った。
・左右前腕に3箇所ずつ3cm×3cmの領域を記し、塗布前の角層水分量を測定した。・表1、又は表2に記載の試料を塗布して、塗布後60分後の角層水分量を測定し角層水分量は塗布前の水分量を100とした値で算出した。
・試料は、3cm×3cmの領域にピペットを用いて9μL滴下し、指サックをした指で均一に塗布した。
・なお角層水分量の測定はSKICON−200EXを用いた。
・角層水分量は、測定当日の気温、湿度等の影響を受けやすいため、一群の試料は同日に評価し、塗布前の測定も試料を塗布した部位での測定値を相対値の基準とした。
[Moisture retention test method]
-The subject performed the test under the guidance of not using cosmetics on the forearm for one week before the test.
・ First, the forearm was washed with a lathering agent.
-The forearm was wiped off and kept at rest for 15 minutes in an environment of 21 ± 0.5 ° C. and 50 ± 5% relative humidity.
-An area of 3 cm x 3 cm was recorded on each of the left and right forearms at three locations, and the water content of the stratum corneum before application was measured. -The samples described in Table 1 or Table 2 were applied, and the water content of the stratum corneum 60 minutes after application was measured.
9 μL of the sample was dropped on a 3 cm × 3 cm area using a pipette, and the sample was uniformly applied with a finger in a finger-sack.
-SKICON-200EX was used for the measurement of the water content of the stratum corneum.
・ The water content of the stratum corneum is easily affected by temperature, humidity, etc. on the day of measurement. did.

Figure 2020015665
Figure 2020015665

Figure 2020015665
Figure 2020015665

Figure 2020015665
Figure 2020015665

表1に示した通り、試料3を塗布することにより、試料1、試料2を単独(それぞれの有効成分量は倍量となる)で塗布した場合と比較して、角層水分量増加効果が相乗的に向上していた。   As shown in Table 1, the effect of increasing the water content of the stratum corneum by applying Sample 3 was smaller than that of applying Sample 1 and Sample 2 alone (the amount of each active ingredient was doubled). It was improving synergistically.

表2に示した通り、試料5を塗布することにより、試料1、試料3を単独(それぞれの有効成分量は倍量となる)で塗布した場合と比較して、角層水分量増加効果が相乗的に向上していた。   As shown in Table 2, the effect of increasing the water content of the stratum corneum was obtained by applying Sample 5 as compared with the case where Samples 1 and 3 were applied alone (the amount of each active ingredient was doubled). It was improving synergistically.

表3に示した通り、試料7を塗布することにより、試料1、試料4を単独(それぞれの有効成分量は倍量となる)で塗布した場合と比較して、角層水分量増加効果が相乗的に向上していた。   As shown in Table 3, the effect of increasing the water content of the stratum corneum was improved by applying Sample 7 as compared with the case where Samples 1 and 4 were applied alone (the amount of each active ingredient was doubled). It was improving synergistically.

[実施例1]クリーム
(1)スクワラン 10.0(質量%)
(2)ステアリン酸 2.0
(3)水素添加パーム核油 0.5
(4)水素添加大豆リン脂質 0.1
(5)セタノール 3.6
(6)親油型モノステアリン酸グリセリン 2.0
(7)グリセリン 10.0
(8)パラオキシ安息香酸メチル 0.1
(9)アルギニン(20質量%水溶液) 15.0
(10)精製水 全量を100とする量
(11)カルボキシビニルポリマー(1質量%水溶液) 15.0
(12)グリセリルグルコシド(東洋精糖社製) 0.5
(13)クマザサ抽出物 0.5
製法:(1)〜(6)の油相成分を80℃にて加熱溶解する。一方(7)〜(10)の水相成分を80℃にて加熱溶解する。これに前記油相成分を攪拌しながら加え、ホモジナイザーにより均一に乳化する。乳化終了後、(11)を加え、冷却を開始し、40℃にて(12)、(13)を加え、均一に混合する。
Example 1 Cream (1) Squalane 10.0 (% by mass)
(2) Stearic acid 2.0
(3) Hydrogenated palm kernel oil 0.5
(4) Hydrogenated soybean phospholipid 0.1
(5) Cetanol 3.6
(6) Lipophilic glyceryl monostearate 2.0
(7) Glycerin 10.0
(8) Methyl paraoxybenzoate 0.1
(9) Arginine (20% by mass aqueous solution) 15.0
(10) Purified water Amount based on the total amount as 100 (11) Carboxyvinyl polymer (1% by mass aqueous solution) 15.0
(12) Glyceryl glucoside (manufactured by Toyo Seika) 0.5
(13) Kumazasa extract 0.5
Production method: The oil phase components (1) to (6) are dissolved by heating at 80 ° C. On the other hand, the aqueous phase components (7) to (10) are heated and dissolved at 80 ° C. The oil phase component is added thereto with stirring, and the mixture is uniformly emulsified by a homogenizer. After the emulsification is completed, (11) is added, cooling is started, and (12) and (13) are added at 40 ° C. and mixed uniformly.

[実施例2]乳液
(1)スクワラン 10.0(質量%)
(2)メチルフェニルポリシロキサン 4.0
(3)水素添加パーム核油 0.5
(4)水素添加大豆リン脂質 0.1
(5)モノステアリン酸ポリオキシエチレン
ソルビタン(20E.O.) 1.3
(6)モノステアリン酸ソルビタン 1.0
(7)グリセリン 4.0
(8)パラオキシ安息香酸メチル 0.1
(9)カルボキシビニルポリマー 0.15
(10)精製水 全量を100とする量
(11)アルギニン(1質量%水溶液) 20.0
(12)グリセリルグルコシド(東洋精糖社製) 0.5
(13)クマザサ抽出物 0.3
製法:(1)〜(6)の油相成分を80℃にて加熱溶解する。一方(7)〜(10)の水相成分を80℃にて加熱溶解する。これに前記油相成分を攪拌しながら加え、ホモジナイザーにより均一に乳化する。乳化終了後、冷却を開始し、(11)〜(13)を順次加え、均一に混合する。
Example 2 Emulsion (1) Squalane 10.0 (% by mass)
(2) Methylphenyl polysiloxane 4.0
(3) Hydrogenated palm kernel oil 0.5
(4) Hydrogenated soybean phospholipid 0.1
(5) Polyoxyethylene monostearate
Sorbitan (20EO) 1.3
(6) Sorbitan monostearate 1.0
(7) Glycerin 4.0
(8) Methyl paraoxybenzoate 0.1
(9) Carboxyvinyl polymer 0.15
(10) Purified water Amount with the total amount being 100 (11) Arginine (1% by mass aqueous solution) 20.0
(12) Glyceryl glucoside (manufactured by Toyo Seika) 0.5
(13) Kumazasa extract 0.3
Production method: The oil phase components (1) to (6) are dissolved by heating at 80 ° C. On the other hand, the aqueous phase components (7) to (10) are heated and dissolved at 80 ° C. The oil phase component is added thereto with stirring, and the mixture is uniformly emulsified by a homogenizer. After completion of the emulsification, cooling is started, and (11) to (13) are sequentially added and uniformly mixed.

[実施例3]化粧水
(1)エタノール 15.0(質量%)
(2)ポリオキシエチレン(40E.O.)硬化ヒマシ油 0.3
(3)香料 0.1
(4)精製水 全量を100とする量
(5)クエン酸 0.02
(6)クエン酸ナトリウム 0.1
(7)グリセリン 1.0
(8)ヒドロキシエチルセルロース 0.1
(9)グリセリルグルコシド(東洋精糖社製) 0.3
(10)ムラヤコエンジー抽出物 0.3
製法:(1)に(2)及び(3)を溶解する。溶解後、(4)〜(8)を順次添加した後、十分に攪拌し、(9)、(10)を加え、均一に混合する。
[Example 3] Lotion (1) Ethanol 15.0 (% by mass)
(2) Polyoxyethylene (40EO) hydrogenated castor oil 0.3
(3) Fragrance 0.1
(4) Purified water Amount based on the total amount as 100 (5) Citric acid 0.02
(6) Sodium citrate 0.1
(7) Glycerin 1.0
(8) Hydroxyethyl cellulose 0.1
(9) Glyceryl glucoside (manufactured by Toyo Seika) 0.3
(10) Murayakoenji extract 0.3
Production method: (2) and (3) are dissolved in (1). After dissolution, (4) to (8) are sequentially added, and then the mixture is sufficiently stirred, and (9) and (10) are added and mixed uniformly.

[実施例4]美容液
(1)精製水 全量を100とする量
(2)グリセリン 10.0(質量%)
(3)ショ糖脂肪酸エステル 1.3
(4)カルボキシビニルポリマー(1質量%水溶液) 17.5
(5)アルギン酸ナトリウム(1質量%水溶液) 15.0
(6)モノラウリン酸ポリグリセリル 1.0
(7)マカデミアナッツ油脂肪酸フィトステリル 3.0
(8)N-ラウロイル-L-グルタミン酸
ジ(フィトステリル−2−オクチルドデシル) 2.0
(9)硬化パーム油 2.0
(10)スクワラン(オリーブ由来) 1.0
(11)ベヘニルアルコール 0.75
(12)ミツロウ 1.0
(13)ホホバ油 1.0
(14)1、3−ブチレングリコール 10.0
(15)L−アルギニン(10質量%水溶液) 2.0
(16)エーデルワイス抽出物 0.2
(17)グリセリルグルコシド(東洋精糖社製) 0.2
(18)クマザサ抽出物 0.15
(19)ムラヤコエンジー抽出物 0.15
(20)冬虫夏草抽出物 0.15
製法:(1)〜(6)の水相成分を混合し、75℃にて加熱溶解する。一方、(7)〜(14)の油相成分を混合し、75℃にて加熱溶解する。次いで、上記水相成分に油相成分を添加して予備乳化を行った後、ホモミキサーにて均一に乳化する。乳化終了後に冷却を開始し、50℃にて(15)を加える。さらに40℃まで冷却し、(16)〜(20)を加え、均一に混合する。
[Example 4] Essence (1) Purified water Amount based on the total amount of 100 (2) Glycerin 10.0 (% by mass)
(3) Sucrose fatty acid ester 1.3
(4) Carboxyvinyl polymer (1% by mass aqueous solution) 17.5
(5) Sodium alginate (1% by mass aqueous solution) 15.0
(6) Polyglyceryl monolaurate 1.0
(7) Macadamia nut oil fatty acid phytosteryl 3.0
(8) N-lauroyl-L-glutamic acid di (phytosteryl-2-octyldodecyl) 2.0
(9) Hardened palm oil 2.0
(10) Squalane (derived from olives) 1.0
(11) Behenyl alcohol 0.75
(12) Beeswax 1.0
(13) Jojoba oil 1.0
(14) 1,3-butylene glycol 10.0
(15) L-arginine (10% by mass aqueous solution) 2.0
(16) Edelweiss extract 0.2
(17) Glyceryl glucoside (manufactured by Toyo Seika Co., Ltd.) 0.2
(18) Kumazasa extract 0.15
(19) Murayakoenji extract 0.15
(20) Cordyceps extract 0.15
Production method: The aqueous phase components (1) to (6) are mixed and heated and dissolved at 75 ° C. On the other hand, the oil phase components (7) to (14) are mixed and heated and dissolved at 75 ° C. Next, after the oil phase component is added to the water phase component to perform preliminary emulsification, the mixture is uniformly emulsified by a homomixer. After completion of the emulsification, cooling is started, and (15) is added at 50 ° C. Further cool to 40 ° C., add (16) to (20), and mix uniformly.

[実施例5]水性ジェル
(1)カルボキシビニルポリマー 0.5(質量%)
(2)精製水 全量を100とする量
(3)水酸化ナトリウム(10質量%水溶液) 0.5
(4)パラオキシ安息香酸メチル 0.1
(5)グリセリルグルコシド(東洋精糖社製) 0.3
(6)ムラヤコエンジー抽出物 0.2
(7)香料 0.1
(8)ポリオキシエチレン(60E.O.)硬化ヒマシ油 0.1
製法:(1)を(2)に加え、均一に攪拌した後、(3)を加える。均一に攪拌した後、(4)〜(8)を加え、均一に攪拌混合する。
Example 5 Aqueous Gel (1) Carboxyvinyl Polymer 0.5 (% by mass)
(2) Purified water Amount with the total amount being 100 (3) Sodium hydroxide (10% by mass aqueous solution) 0.5
(4) Methyl paraoxybenzoate 0.1
(5) Glyceryl glucoside (manufactured by Toyo Seika) 0.3
(6) Murayakoenji extract 0.2
(7) Fragrance 0.1
(8) Polyoxyethylene (60EO) hydrogenated castor oil 0.1
Production method: (1) is added to (2), and after stirring uniformly, (3) is added. After uniformly stirring, (4) to (8) are added and uniformly stirred and mixed.

[実施例6]クレンジング料
(1)スクワラン 81.0(質量%)
(2)イソステアリン酸ポリオキシエチレングリセリル 15.0
(3)精製水 全量を100とする量
(4)グリセリルグルコシド(東洋精糖社製) 0.2
(5)冬虫夏草抽出物 0.5
製法:(1)と(2)を均一に溶解する。これに、(3)〜(5)を順次加え、均一に混合する。
Example 6 Cleansing Charge (1) Squalane 81.0 (% by mass)
(2) Polyoxyethylene glyceryl isostearate 15.0
(3) Purified water Amount with the total amount being 100 (4) Glyceryl glucoside (manufactured by Toyo Seika) 0.2
(5) Cordyceps extract 0.5
Production method: (1) and (2) are uniformly dissolved. To this, (3) to (5) are sequentially added and mixed uniformly.

[実施例7]洗顔フォーム
(1)ステアリン酸 16.0(質量%)
(2)ミリスチン酸 16.0
(3)親油型モノステアリン酸グリセリン 2.0
(4)グリセリン 20.0
(5)水酸化ナトリウム 7.5
(6)ヤシ油脂肪酸アミドプロピルベタイン 1.0
(7)精製水 全量を100とする量
(8)グリセリルグルコシド(東洋精糖社製) 0.4
(9)クマザサ抽出物 0.4
製法:(1)〜(4)の油相成分を80℃にて加熱溶解する。一方(5)〜(7)の水相成分を80℃にて加熱溶解し、油相成分と均一に混合撹拌する。冷却を開始し、40℃にて(8)、(9)を加え、均一に混合する。
[Example 7] Facial cleansing foam (1) Stearic acid 16.0 (% by mass)
(2) myristic acid 16.0
(3) Lipophilic glyceryl monostearate 2.0
(4) Glycerin 20.0
(5) Sodium hydroxide 7.5
(6) Coconut oil fatty acid amidopropyl betaine 1.0
(7) Purified water Amount with the total amount being 100 (8) Glyceryl glucoside (manufactured by Toyo Seika Co., Ltd.) 0.4
(9) Kumazasa extract 0.4
Production method: The oil phase components (1) to (4) are heated and dissolved at 80 ° C. On the other hand, the aqueous phase components (5) to (7) are heated and dissolved at 80 ° C., and uniformly mixed and stirred with the oil phase components. Start cooling, add (8) and (9) at 40 ° C and mix uniformly.

[実施例8]メイクアップベースクリーム
(1)スクワラン 10.0(質量%)
(2)セタノール 2.0
(3)グリセリントリ−2−エチルヘキサン酸エステル 2.5
(4)親油型モノステアリン酸グリセリル 1.0
(5)プロピレングリコール 11.0
(6)ショ糖脂肪酸エステル 1.3
(7)精製水 全量を100とする量
(8)酸化チタン 1.0
(9)ベンガラ 0.1
(10)黄酸化鉄 0.4
(11)香料 0.1
(12)グリセリルグルコシド(東洋精糖社製) 0.2
(13)ムラヤコエンジー抽出物 0.1
製法:(1)〜(4)の油相成分を混合し、75℃にて加熱溶解する。一方、(5)〜(7)の水相成分を混合し、75℃にて加熱溶解し、これに(8)〜(10)の顔料を加え、ホモミキサーにて均一に分散させる。この水相成分に前記油相成分を加え、ホモミキサーにて乳化する。乳化終了後に冷却を開始し、40℃にて(11)〜(13)の成分を加え、均一に混合する。
Example 8 Makeup Base Cream (1) Squalane 10.0 (% by mass)
(2) Cetanol 2.0
(3) Glycerin tri-2-ethylhexanoate 2.5
(4) Lipophilic glyceryl monostearate 1.0
(5) Propylene glycol 11.0
(6) Sucrose fatty acid ester 1.3
(7) Purified water Amount with the total amount being 100 (8) Titanium oxide 1.0
(9) Bengala 0.1
(10) Yellow iron oxide 0.4
(11) Fragrance 0.1
(12) Glyceryl glucoside (manufactured by Toyo Seika) 0.2
(13) Murayakoenji extract 0.1
Production method: The oil phase components (1) to (4) are mixed and dissolved by heating at 75 ° C. On the other hand, the aqueous phase components (5) to (7) are mixed and dissolved by heating at 75 ° C., and the pigments (8) to (10) are added thereto and uniformly dispersed by a homomixer. The oil phase component is added to the water phase component and emulsified by a homomixer. After completion of the emulsification, cooling is started, and the components (11) to (13) are added at 40 ° C. and uniformly mixed.

[実施例9]乳液状ファンデーション
(1)メチルポリシロキサン 2.0(質量%)
(2)スクワラン 5.0
(3)ミリスチン酸オクチルドデシル 5.0
(4)セタノール 1.0
(5)ポリオキシエチレン(20E.O.)
ソルビタンモノステアリン酸エステル 1.3
(6)モノステアリン酸ソルビタン 0.7
(7)1、3−ブチレングリコール 8.0
(8)キサンタンガム 0.1
(9)パラオキシ安息香酸メチル 0.1
(10)精製水 全量を100とする量
(11)酸化チタン 9.0
(12)タルク 7.4
(13)ベンガラ 0.5
(14)黄酸化鉄 1.1
(15)黒酸化鉄 0.1
(16)香料 0.1
(17)グリセリルグルコシド(東洋精糖社製) 0.2
(18)冬虫夏草抽出物 0.1
製法:(1)〜(6)の油相成分を混合し、75℃にて加熱溶解する。一方、(7)〜(10)の水相成分を混合し、75℃にて加熱溶解し、これに(11)〜(15)の顔料を加え、ホモミキサーにて均一に分散する。油相成分を加え、乳化を行う。乳化終了後に冷却を開始し、40℃にて(16)〜(18)の成分を順次加え、均一に混合する。
Example 9 Emulsion Foundation (1) Methylpolysiloxane 2.0 (% by mass)
(2) Squalane 5.0
(3) Octyldodecyl myristate 5.0
(4) Cetanol 1.0
(5) Polyoxyethylene (20EO)
Sorbitan monostearate 1.3
(6) Sorbitan monostearate 0.7
(7) 1,3-butylene glycol 8.0
(8) Xanthan gum 0.1
(9) Methyl paraoxybenzoate 0.1
(10) Purified water Amount with the total amount being 100 (11) Titanium oxide 9.0
(12) Talc 7.4
(13) Bengala 0.5
(14) Yellow iron oxide 1.1
(15) Black iron oxide 0.1
(16) Fragrance 0.1
(17) Glyceryl glucoside (manufactured by Toyo Seika Co., Ltd.) 0.2
(18) Cordyceps extract 0.1
Production method: The oil phase components (1) to (6) are mixed and dissolved by heating at 75 ° C. On the other hand, the aqueous phase components (7) to (10) are mixed and dissolved by heating at 75 ° C., and the pigments (11) to (15) are added thereto and uniformly dispersed by a homomixer. Add oil phase components and emulsify. After the completion of the emulsification, cooling is started, and the components (16) to (18) are sequentially added at 40 ° C. and uniformly mixed.

[実施例10]油中水型エモリエントクリーム
(1)流動パラフィン 30.0(質量%)
(2)マイクロクリスタリンワックス 2.0
(3)ワセリン 5.0
(4)ジグリセリンオレイン酸エステル 5.0
(5)塩化ナトリウム 1.3
(6)塩化カリウム 0.1
(7)プロピレングリコール 3.0
(8)1、3−ブチレングリコール 5.0
(9)パラオキシ安息香酸メチル 0.1
(10)グリセリルグルコシド(東洋精糖社製) 0.2
(11)冬虫夏草抽出物 0.1
(12)精製水 全量を100とする量
(13)香料 0.1
製法:(5)と(6)を(12)の一部に溶解して50℃とし、50℃に加熱した(4)に撹拌しながら徐々に加える。これを混合した後、70℃にて加熱溶解した(1)〜(3)に均一に分散する。これに(7)〜(11)を(12)の残部に70℃にて加熱溶解したものを撹拌しながら加え、ホモミキサーにて乳化する。乳化終了後に冷却を開始し、40℃にて(13)を加え、均一に混合する。
[Example 10] Water-in-oil emollient cream (1) Liquid paraffin 30.0 (% by mass)
(2) Microcrystalline wax 2.0
(3) Vaseline 5.0
(4) Diglycerin oleate 5.0
(5) Sodium chloride 1.3
(6) Potassium chloride 0.1
(7) Propylene glycol 3.0
(8) 1,3-butylene glycol 5.0
(9) Methyl paraoxybenzoate 0.1
(10) Glyceryl glucoside (manufactured by Toyo Seika Co., Ltd.) 0.2
(11) Cordyceps extract 0.1
(12) Purified water Total amount to 100 (13) Fragrance 0.1
Production method: (5) and (6) are dissolved in a part of (12) to 50 ° C., and gradually added to (4) heated to 50 ° C. with stirring. After mixing, the mixture is heated and dissolved at 70 ° C. and uniformly dispersed in (1) to (3). A mixture obtained by heating and dissolving (7) to (11) in the remainder of (12) at 70 ° C. is added thereto with stirring, and emulsified by a homomixer. After emulsification is completed, cooling is started, (13) is added at 40 ° C., and the mixture is uniformly mixed.

[実施例11]パック
(1)精製水 全量を100とする量
(2)ポリビニルアルコール 12.0(質量%)
(3)エタノール 17.0
(4)グリセリン 5.0
(5)ポリエチレングリコール(平均分子量1000) 2.0
(6)グリセリルグルコシド(東洋精糖社製) 0.2
(7)クマザサ抽出物 0.2
(8)香料 0.1
製法:(2)と(3)を混合し、80℃に加温した後、80℃に加温した(1)に溶解する。均一に溶解した後、(4)と(5)を加え、攪拌しながら冷却を開始する。40℃まで冷却し、(6)〜(8)を加え、均一に混合する。
[Example 11] Pack (1) Purified water Amount based on the total amount of 100 (2) Polyvinyl alcohol 12.0 (% by mass)
(3) Ethanol 17.0
(4) Glycerin 5.0
(5) polyethylene glycol (average molecular weight 1000) 2.0
(6) Glyceryl glucoside (manufactured by Toyo Seika) 0.2
(7) Kumazasa extract 0.2
(8) Fragrance 0.1
Production method: (2) and (3) are mixed, heated to 80 ° C, and dissolved in (1) heated to 80 ° C. After uniform dissolution, (4) and (5) are added, and cooling is started with stirring. Cool to 40 ° C., add (6) to (8), and mix uniformly.

[実施例12]入浴剤
(1)香料 0.3(質量%)
(2)グリセリルグルコシド(東洋精糖社製) 0.2
(3)ムラヤコエンジー抽出物 0.2
(4)炭酸水素ナトリウム 50.0
(5)硫酸ナトリウム 49.3
製法:(1)〜(5)を均一に混合する。
Example 12 Bath agent (1) Fragrance 0.3 (% by mass)
(2) Glyceryl glucoside (manufactured by Toyo Seika Co., Ltd.) 0.2
(3) Murayakoenji extract 0.2
(4) Sodium bicarbonate 50.0
(5) Sodium sulfate 49.3
Production method: (1) to (5) are mixed uniformly.

[実施例13]シート状パック
(1)香料 0.1(質量%)
(2)1,3−ブチレングリコール 5.0
(3)グリセリン 5.0
(4)エタノール 3.0
(5)グリセリルグルコシド(東洋精糖社製) 0.2
(6)冬虫夏草抽出物 0.2
(7)精製水 全量を100とする量
製法:(1)〜(7)を均一に混合したのち、不織布性のシートに含浸させる。
Example 13 Sheet Pack (1) Fragrance 0.1 (% by mass)
(2) 1,3-butylene glycol 5.0
(3) Glycerin 5.0
(4) Ethanol 3.0
(5) Glyceryl glucoside (manufactured by Toyo Seika) 0.2
(6) Cordyceps extract 0.2
(7) Purified water A quantity production method in which the total amount is 100: After uniformly mixing (1) to (7), a nonwoven sheet is impregnated.

Claims (1)

下記(A)及び(B)を含有する皮膚外用剤。
(A)グリセリルグルコシド
(B)クマザサ抽出物、ムラヤコエンジー抽出物、冬虫夏草抽出物から選択される1種または2種以上
An external preparation for skin containing the following (A) and (B).
(A) glyceryl glucoside (B) one or more selected from Kumazasa extract, Murayakoenji extract, Cordyceps sinensis extract
JP2018137330A 2018-07-23 2018-07-23 Topical skin preparation Active JP6416433B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2018137330A JP6416433B1 (en) 2018-07-23 2018-07-23 Topical skin preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2018137330A JP6416433B1 (en) 2018-07-23 2018-07-23 Topical skin preparation

Publications (2)

Publication Number Publication Date
JP6416433B1 JP6416433B1 (en) 2018-10-31
JP2020015665A true JP2020015665A (en) 2020-01-30

Family

ID=64017146

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018137330A Active JP6416433B1 (en) 2018-07-23 2018-07-23 Topical skin preparation

Country Status (1)

Country Link
JP (1) JP6416433B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7471098B2 (en) 2020-02-03 2024-04-19 株式会社ノエビア Skin preparations

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020094000A (en) * 2018-12-13 2020-06-18 株式会社ノエビア Skin external preparation

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07118132A (en) * 1993-10-18 1995-05-09 Shiseido Co Ltd Ultraviolet-absorbing skin cosmetic
JPH11199467A (en) * 1998-01-06 1999-07-27 Nonogawa Shoji Kk Skin preparation for external use
JPH11222496A (en) * 1998-02-02 1999-08-17 Tatsuuma Honke Brewing Co Ltd Alpha-d-glucopyranosylglycerol compounds, production thereof and use thereof
JP2003292430A (en) * 2002-04-01 2003-10-15 Noevir Co Ltd Skin care preparation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07118132A (en) * 1993-10-18 1995-05-09 Shiseido Co Ltd Ultraviolet-absorbing skin cosmetic
JPH11199467A (en) * 1998-01-06 1999-07-27 Nonogawa Shoji Kk Skin preparation for external use
JPH11222496A (en) * 1998-02-02 1999-08-17 Tatsuuma Honke Brewing Co Ltd Alpha-d-glucopyranosylglycerol compounds, production thereof and use thereof
JP2003292430A (en) * 2002-04-01 2003-10-15 Noevir Co Ltd Skin care preparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7471098B2 (en) 2020-02-03 2024-04-19 株式会社ノエビア Skin preparations

Also Published As

Publication number Publication date
JP6416433B1 (en) 2018-10-31

Similar Documents

Publication Publication Date Title
JP5171206B2 (en) Moisturizer and external preparation for skin
US9724291B2 (en) External skin preparation
KR102428341B1 (en) Composition for the natural surfactant and cosmetic composition containing Saponaria officinalis, Yucca Schidigera and Quillaia saponaria MOLINA
JP6416433B1 (en) Topical skin preparation
JP6622015B2 (en) External preparation for skin or cosmetics
JP3991164B2 (en) Cosmetic composition comprising jujube extract and walnut extract
JP2022173364A (en) Skin external preparation
JP6315533B1 (en) Topical skin preparation
JP4105498B2 (en) A composition effective for prevention and alleviation of symptoms of atopic disease
JP5795146B2 (en) Moisturizer and external preparation for skin
JP7218166B2 (en) Skin topical agent
JP2006083112A (en) Skin care preparation for external use
JP2009057309A (en) Skin preparation for external use and humectant
JP2004123661A (en) Skin care preparation for external use
JP3822517B2 (en) Topical skin preparation
JP5116428B2 (en) Moisturizer and external preparation for skin
JP5455634B2 (en) Skin preparations and moisturizers
JP2020094001A (en) Skin external preparation
JP2009046425A (en) Skin care preparation for external use and humectant
JP3887596B2 (en) Skin preparation for moisturizing and skin preparation for improving rough skin
JP2004137166A (en) Skin care preparation for external use, cell activator and antioxidant
JP3543306B2 (en) Cell activator and antioxidant
JP5610806B2 (en) Antioxidants and external preparations for skin
JP2011063513A (en) Anti-aging agent and external preparation for skin
JP2004018498A (en) Skin external preparation

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180723

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20180723

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20180802

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180814

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20181002

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20181003

R150 Certificate of patent or registration of utility model

Ref document number: 6416433

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150